24-2èŠéæ€æ»ãšã¯äœãïŒ
èŠéæ€æ»ã¯ãäžå¿èŠèŠã ãã§ãªããåšèŸºïŒåŽæ¹ïŒèŠèŠã§äœãèŠããŠããããæž¬å®ããéèŠãªæ¹æ³ã§ãã24-2æ€æ»ã¯ãç·å éæ²»çã§çšããããèªåèŠéæ€æ»ã®ç¹å®ã®ã¿ã€ãã§ããç°¡åã«èšãã°ã24-2æ€æ»ã§ã¯ãæ©æ¢°ïŒå€ãã®å Žåããã³ããªãŒèŠéèšïŒã«åº§ããåºå®ãããã¿ãŒã²ããããŸã£ããèŠã€ããŸããå°ããªå ïŒåºæ¿ãšåŒã°ããïŒãèŠéå ã®æ§ã ãªç®æã§ç¹æ» ããŸããå ãèŠãããã³ã«ãã¿ã³ãæŒããŸããæ©æ¢°ã¯ãããªããèŠãç¹ãšèŠéããç¹ãèšé²ããŸããããã«ãããæ£åžžãªèŠèŠé åãšãããªãã«ååšããå¯èœæ§ã®ããæç¹ãæåºŠã®äœäžã瀺ãèŠéã®å°å³ãäœæãããŸããç·å éã¯ç¶²èã®ç¹å®ã®ç¥çµç·ç¶å±€ãæå·ããããã24-2ãã¿ãŒã³ã¯ãäžå¿24床ã®èŠéå šäœã§æãäžè¬çãªç·å éã®æ¬ æïŒæ¹Ÿæ²ãããåŒç¶ãæç¹ãåäžå¿æ§èŠéæ¬ æã錻åŽé段ãªã©ïŒãå¹ççã«æ€åºããããã«èšèšãããŠããŸã (www.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov)ãããã¯ãäžçäžã®ç·å éè©äŸ¡ã§æãåºã䜿çšãããŠããæšæºçãªèŠéæ€æ»ã§ãã
ã24-2ãã®æå³
ã24-2ããšããåç§°ã¯ããããã«ããŒããèŠéé åãšãã¿ãŒã³ã®ééã«ç±æ¥ããŸããã24ãã¯ãæ€æ»ãããªãã®èŠèŠã®äžå¿24床ãå šæ¹åã«ã«ããŒããããšïŒèŠã€ããç¹ããããã24°ã®ååŸïŒãæå³ããŸããããã«ã¯äžå¿èŠèŠãšäžéšã®åšèŸºèŠèŠãå«ãŸããŸãããæå€çžãŸã§ã¯å°éããŸããã**ãâ2ã**ã¯åœåèŠåã«ãããæè¡çãªè©³çްã§ããããã¯åºæ¬çã«ãæ€æ»ç¹ãåçŽãŸãã¯æ°Žå¹³è»žäžã«æ£ç¢ºã«ã¯ãªãããããã®ç·ãã2床ãããŠããããšãæå³ããŸããå®çšçãªæå³åããšããŠã¯ããã®æ€æ»ã¯æ³šèŠç¹åšèŸºã®äžå¿åè§é åïŒÂ±24°ïŒã«çŠç¹ãåœãŠãæ€æ»ç¹ã¯6°ééã®ã°ãªãããã¿ãŒã³ã§é 眮ãããŠããŸã (pmc.ncbi.nlm.nih.gov) (www.ncbi.nlm.nih.gov)ãå®éã«ã¯ããâ2ãã®æ£ç¢ºãªæå³ã«ã€ããŠå¿é ããå¿ èŠã¯ãããŸããã24-2ãæšæºçãªãã¿ãŒã³ã§ãããå»åž«ã¯å€åã远跡ããéã«åžžã«åçš®ã®ãã®ãæ¯èŒããããšãç¥ã£ãŠããã°ååã§ãã
24-2ã°ãªããã®èšè𿹿³
24-2æ€æ»ã¯ãäžå¿èŠèŠã«åºãã54ã®æ€æ»ç¹ã®ã°ãªããã䜿çšããŸãããããã®ç¹ã¯ãããã6床ééã§é 眮ãããŠããŸãïŒ8Ã7ã®ã°ãªãããæ³åããŠãã ããïŒ (pmc.ncbi.nlm.nih.gov)ããã®ééãçè§£ããŠãã ãããããè¿ãã®4ã€ã®ç¹ãåè§åœ¢ã«çµãã å Žåãäžå¿ã«ã¯æ©æ¢°ãæ€æ»ããªãããã3°ã®ééïŒååŸïŒããããŸãããã®èšèšã¯ãç¶²çŸ æ§ãšé床ã®éã®åŠ¥åç¹ãšããŠéžã°ããŸãããããå€ãã®ç¹ãããã°è©³çްãæããããŸãããæ€æ»ãã¯ããã«é·ããªããããç²åŽå°æãããŸããç¹ã6°ééã«ä¿ã€ããšã§ã24-2æ€æ»ã¯éåžžãSITA Standardã¢ãŒãã§ççŒã«ã€ãçŽ5å以äžã§å®äºã (glaucomatoday.com)ãã»ãšãã©ã®æ£è ïŒé«éœ¢è ãå«ãïŒã«ãšã£ãŠå®è¡å¯èœãªæéã§ãã
éèŠãªã®ã¯ããã®ãã¿ãŒã³ãç·å éã®ããã«èª¿æŽãããŠããããšã§ããèŠèŠã®éŒ»åŽïŒå åŽïŒã«ããã€ãã®è¿œå ã®ç¹ãä¿æããŠãããããã¯ç¹ã«ç·å éã®å žåçãªã錻åŽéæ®µãæ¬ æãæ€åºããããã§ã (www.ncbi.nlm.nih.gov)ããŸããæç¹ããåºãèŠèŠã®äžéšãšäžéšã®äž¡æ¹ã®åŒç¶éšåãã«ããŒããŠãããç·å éã¯ãã°ãã°åŒç¶ïŒåŒåœ¢ïŒã®æç¹ãåŒãèµ·ãããŸããèšãæããã°ã24-2ã°ãªããã¯ãç·å éã«ãã£ãŠæåã«æå·ãåããããæ¹æ³ã§èŠç¥çµã«ä¿¡å·ãéãç¶²èã®é åãæ€æ»ããŸããå®éãå€§èŠæš¡ãªç ç©¶ã§ã¯ãç·å éãé²è¡ããå Žåã24-2èŠéã®éŒ»åŽããã³åäžå¿é åãæãé »ç¹ã«æå·ãåããããšã瀺ãããŠããŸã (pmc.ncbi.nlm.nih.gov)ããããã®é åãšåšå²ã®ç¶²èãã«ããŒããããšã§ã24-2æ€æ»ã¯ãæ€æ»æéãšæ£è ã®ç²åŽã劥åœãªç¯å²ã«æãã€ã€ãå žåçãªç·å éæ§èŠéæ¬ æãæ€åºããæ©äŒãæå€§éã«é«ããŸã (www.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov)ã
å€ã30-2æ€æ»ïŒ30°ãã«ããŒã76ç¹ïŒãšæ¯èŒããŠã24-2ãã¿ãŒã³ã¯åçŽã«æãå€åŽã®ç¹ã®ãªã³ã°ãåé€ããæãéèŠãª54ç¹ãæ®ããŠããŸããããã«ããã24-2ã¯ãããã«é«éã«ãªããç²åŽã軜æžãããåœé°æ§å¿çïŒå ä¿¡å·ã®èŠéãïŒãæžããããšãã§ããŸã (www.ncbi.nlm.nih.gov)ãå®éã«ã¯ãã»ãšãã©ã®ç·å éå°éå»ã¯æ¥åžžçãªæ€æ»ã«24-2ã奜ã¿ãŸãããªããªããããã¯åªãããã©ã³ã¹ãåã£ãŠããããã§ããæãè匱ãªé åïŒéŒ»åŽé段ãäžäžåŒç¶é åãããã³åäžå¿èŠèŠïŒã培åºçã«è©äŸ¡ãã€ã€ãç·å éããã£ãã«åœ±é¿ããªãé æ¹ã®åšèŸºç¹ãéå°ã«æ€æ»ããããšã¯ãããŸããã
ãªã24-2ãæšæºãšãªã£ãã®ã
ãã®å·§åŠãªèšèšãšæ°å幎ã«ããã䜿çšã«ããã24-2ã¯äžçäžã§ç·å éã®æšæºçãªèŠéæ€æ»ãšãªããŸãããã»ãšãã©ãã¹ãŠã®äž»èŠãªç·å éèšåºè©Šéšãšç ç©¶ããŒã¿ããŒã¹ã24-2èŠéã䜿çšããŠããããGuided Progression AnalysisããVisual Field Indexã®ãããªãã¹ãŠã®èªååæããŒã«ã¯24-2ããŒã¿ã§æ©èœããããã«æ§ç¯ãããŠããŸããããã¯ãåºæºãšãªãæ£åžžããŒã¿ïŒå èµããããæ£åžžãå€ïŒãšé²è¡ã¢ã«ãŽãªãºã ããã¹ãŠ24-2ã«åºã¥ããŠããããšãæå³ããŸããäŸãã°ãçŒç§çšæ©åšã¯ã54ã®åå°ç¹ã§ã®ããªãã®çµæããå¥åžžè ããåéãããå èµã®å¹Žéœ¢äžèŽæ£åžžããŒã¿ããŒã¹ãšæ¯èŒããŸã (www.ncbi.nlm.nih.gov) (glaucomatoday.com)ãïŒéåžžããœãããŠã§ã¢ã¯å¥åžžè ã®å¿çã®äžäœ95%ããæ£åžžããšããäžäœ5%ãå¯èœæ§ã®ããæ¬ æãšããŠããŒã¯ããŸã (www.ncbi.nlm.nih.gov)ãïŒ24-2æ€æ»ãåãããã³ã«ãã³ã³ãã¥ãŒã¿ãŒã¯åç¹ã§ã®ããªãã®æåºŠãå幎霢ã®äººã ãšã©ã®ããã«æ¯èŒããããã瀺ããŸããå šäœçãªèŠçŽæ°å€ã§ããå¹³ååå·®ïŒMDïŒã¹ã³ã¢ã§ããããããã®åºæºã«åºã¥ããŠããŸãã
ãã®åºç€ããããããæ£è ã®èŠéã«é¢ããé·æç ç©¶ïŒäŸãã°ãOcular Hypertension Treatment StudyïŒã§ã¯ã24-2ã°ãªããäžã§é²è¡ãç¹ããšã«è¿œè·¡ãããŠããŸã (pmc.ncbi.nlm.nih.gov)ãå®éãOHTSããŒã¿ã®åæã§ã¯ã24-2ã°ãªããäžã®52ã®åæå¯èœãªåç¹ã«ãããé²è¡çã調æ»ããã»ãšãã©ã®å€åã錻åŽããã³å åŽïŒåäžå¿ïŒé åã§çºçããŠããããšã確èªããŸãã (pmc.ncbi.nlm.nih.gov)ããã®ãããªæ°å幎ã«ãããããŒã¿ããããšããããšã¯ãå»åž«ã24-2ã®æ£åžžç¯å²ãšé²è¡ã®å åãä¿¡é ŒããŠããããšãæå³ããŸããæ£è ãšããŠã¯ãããªãã®çŒç§å»ãïŒç¹ã«ç·å éã¯ãªããã¯ã§ïŒã»ãšãã©åžžã«24-2ãã¿ãŒã³ã䜿çšãããšããããšã§ãããªããªãããããæãå ç¢ãªèšé²ãæã¡ããœãããŠã§ã¢ããŒã«ïŒGPAãªã©ïŒããããšã·ãŒã ã¬ã¹ã«é£æºããããã§ã (glaucomatoday.com) (www.ncbi.nlm.nih.gov)ã
24-2ãããã³ã«ã®åŒ·ã¿
24-2æ€æ»ãäž»èŠãªå°äœãå ããã®ã¯ãããã€ãã®åŒ·ã¿ãããããã§ãã
-
ååã«æ€èšŒãããæ£åžžããŒã¿ã ãã³ããªãŒèŠéèšãé·å¹Žäœ¿çšãããŠããããããã®å èµ24-2ããŒã¿ããŒã¹ã¯å€§èŠæš¡ã§ä¿¡é Œæ§ããããŸããæ€æ»ãããã¹ãŠã®ç¹ã¯ãããªãã®å¹Žéœ¢å±€ã®å¥åº·ãªç®ãšæ¯èŒãããŸã (glaucomatoday.com)ãäŸãã°ã69æ³ã®æ£è ã¯60ïœ69æ³ã®ããŒã¿ããŒã¹ãšæ¯èŒããã70æ³ã«ãªããš70ïœ79æ³ã®ã°ã«ãŒããšæ¯èŒãããŸã (glaucomatoday.com)ãèŠèŠæåºŠã¯å¹Žéœ¢ãšãšãã«äœäžããããããã®å¹Žéœ¢ãããã³ã°ã¯éèŠã§ãããã®ãããªæŽç·Žãããæ£åžžããŒã¿ããŒã¹ãæã€ããšã§ãæ£åžžèŠèŠããã®å®éã®éžè±ããã容æã«ç¹å®ã§ããŸãã
-
ç ç©¶ããã®èšŒæ ã 24-2ãæ°å幎ã«ãããäž»åã§ãã£ãããããã®çµæçãªæåã瀺ãèšå€§ãªç ç©¶åºç€ããããŸãããã®ã¹ã³ã¢ãã©ã®ããã«å€åãã24-2æ€æ»ã§é²è¡ãã©ã®ããã«èŠããããçè§£ããŠããŸããå€ãã®éèŠãªç·å éã®çºèŠïŒå žåçãªé²è¡é床ãå±éºå åãªã©ïŒã¯24-2ããŒã¿ããåŸãããŸããã
-
é²è¡ããŒã«ïŒGPAãVFIãªã©ïŒã ãã³ããªãŒèŠéèšã¯ãäžé£ã®24-2æ€æ»ã䜿çšããŠãã¬ã³ãã©ã€ã³ïŒèŠèŠèŠéææ°ãªã©ïŒãèšç®ããç·å éé²è¡è§£æïŒGPAïŒãå®è¡ããŸãããããã®ããŒã«ã¯ãè€æ°ã®æ¥é¢ã«ãããçµ±èšçã«ææãªå€åãããŒã¯ããŸããäŸãã°ãGPAãœãããŠã§ã¢ã¯ãç¹°ãè¿ãã®24-2æ€æ»ã«åºã¥ããŠåç¹ããæ¹åãããæªåãããŸãã¯ãå®å®ãã«åé¡ããŸãããããã®ããŒã«ã¯24-2ã®ã¬ã€ã¢ãŠãã«åºã¥ããŠæ§ç¯ãããŠãããããåžžã«24-2ã䜿ãç¶ããããšã§ãå»åž«ã¯ãããã®é²è¡ã°ã©ãããã¬ãŒã¯ãã€ã³ãã¢ã©ãŒãã«é Œãããšãã§ããŸãã
-
ç·å éã®è匱é åãã¿ãŒã²ããã«ããç¶²çŸ æ§ã åè¿°ã®éãã24-2ã¯54ã®ç¹ã錻åŽé段ãåŒç¶æé åãåäžå¿é»æéšïŒç·å éã§æãé »ç¹ã«åœ±é¿ãåããé åïŒãã«ããŒããããã«ãã©ã³ã¹ãåã£ãŠããŸããç·å éæ²»çã«ãããŠé¢é£æ§ãäœã24°ãè¶ ããæå€åšãªã³ã°ã¯é€å€ããæ©æã®éŒ»åŽé段ïŒç·å éã®ç¹åŸŽïŒãèŠéããªãããã«ã錻åŽã®2ç¹ãç¹ã«ç¶æããŠããŸã (www.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov)ãæ¥åžžèšºçã§ã¯ãããã¯24-2ãç·å éãã奜ãã§å§ãŸããèŠéãããã®é åãå¹ççã«ãµã³ããªã³ã°ããããšãæå³ããŸãã
æ£è ã«ãšã£ãŠæ¥åžžçãªèšèã§èšãã°ããããã®åŒ·ã¿ã¯ã24-2æ€æ»ãã»ãšãã©ã®çŒç§å»ã«éŠŽæã¿æ·±ããé·å¹Žã®ããŒã¿ã«è£æã¡ãããŠããããããã«ç·å éæ§ã®æ¬ æãèŠãããŸããïŒããšããåãã«å¯ŸããŠä¿¡é Œã§ããã¯ã/ãããã®åçãããããããšãæå³ããŸããäŸãã°ãããªã³ãã¢ãŠãã®**ç·å éåèŠéãã¹ãïŒGHTïŒã¯ãåçŒã®èŠéã®äžååãšäžååãæ¯èŒããŸãããããæ£åžžç¯å²å€ããšç€ºãããå Žåãããã¯éåžžãç·å éã®ãã¿ãŒã³ãšäžèŽããŸã (glaucomatoday.com)ã24-2ã®ããªã³ãã¢ãŠãã«ããå¹³ååå·®ïŒMDïŒ**ã¹ã³ã¢ïŒå šäœçãªèŠçŽïŒããå 霢ã«ããæ£åžžå€ã«ããæ ¡æ£ãããŠãããããæå³ã®ãããã®ã§ã (glaucomatoday.com)ã
éçãšèŠéãããæå·
ãã®åŒ·ã¿ã«ããããããã24-2ã°ãªããã«ã¯éçããããŸããç¹ã«äžå¿èŠèŠè¿ãã®åææå·ãèŠã€ããéã«ã¯ãç¹ã6°é¢ããŠãããããå°ããªæç¹ãç¹ã®éã«ãé ããŠãããŸãå¯èœæ§ããããŸããç¹ã«ã24-2ã¯äžå¿10°ïŒå åŽèŠèŠïŒå ã«ããã12ã®æ€æ»ç¹ããå«ãã§ããŸãã (pmc.ncbi.nlm.nih.gov)ããããã黿éšïŒäžå¿10°ïŒã¯**å šç¶²èç¥çµç¯çްèã®çŽ30%**ãå«ã¿ãè³ã®èŠèŠå ¥åã®åå以äžãå ããŠããŸã (pmc.ncbi.nlm.nih.gov)ãç·å éã§ã¯ã黿éšãžã®æå·ã¯åææ®µéã§ãçºçããå¯èœæ§ããããŸãã
ç°¡åã«èšãã°ãå€ãã®ç ç©¶ãã24-2æ€æ»ãåæã®äžå¿ãŸãã¯åäžå¿æ¬ æãèŠéãå¯èœæ§ãããããšã瀺ããŠããŸããããæšªæç ç©¶ã§ã¯ããæ£åžžããª24-2èŠéãæã€çŒã®16%ããå¯ãª10-2ã°ãªããã§æ€æ»ãããéã«å®éã«ã¯ææãªæç¹ãæããŠããããšã倿ããŸãã (pmc.ncbi.nlm.nih.gov)ãå¥ã®ç ç©¶ã§ã¯ã軜床ç·å 鿣è ïŒèŠéå¹³ååå·®ãâ6 dBããè¯å¥œïŒã®ãã¡ã74%ã10-2æ€æ»ã§åäžå¿æ§æç¹ãæããŠãããã24-2ã§ã¯è»œåºŠã®èŠéæ¬ æãã瀺ããªãã£ãããšãæããã«ãªããŸãã (pmc.ncbi.nlm.nih.gov)ãå®éã«ã¯ãããã¯æ£è ãæ³šèŠç¹è¿ãã«å°ããªèŠéæ¬ æã®ç¹ãæã£ãŠããŠãã24-2ã§ã¯æ€åºãããªãå¯èœæ§ãããããšãæå³ããŸãïŒå³1ïŒã
èšåºçã«ã¯ããããã®éçã¯ããç¥ãããŠããŸããGlaucoma Todayã®ã¬ã€ãã§ããã*ãåäžå¿æ§æç¹ã¯24-2ã§èŠéãããå¯èœæ§ããã... 24-2ã§æ³šèŠç¹ã«è¿ãæ¬ æãããå Žåã¯10-2ã§åæ€æ»ãã¹ãã§ããããšå©èšããŠããŸã (www.ncbi.nlm.nih.gov)ãèšãæããã°ãããªãïŒãŸãã¯ããªãã®å»åž«ïŒãäœãMDã埮åŠãªå åããäžå¿è¿ãã«äœããã®åé¡ãçãå Žåã24-2ã§ã¯äžååãããããŸãããå®éã黿æå·ã®åæã§ã¯ãã24-2èŠéã®ã¿ã宿œãããå Žåã黿ãžã®ç·å éæ§æå·ã¯èšåºèšºçã§èŠéãããã*ãšæç¢ºã«çµè«ä»ããããŠããŸã (pmc.ncbi.nlm.nih.gov)ã
ããã«ã24-2ã¯24°ãè¶ ããé ãåšèŸºèŠèŠãæ€æ»ããŸãããç·å éã®å Žåãéåžžã¯ããã§ååã§ããïŒç·å éã¯éåžžãããäžå¿ã«è¿ãèŠéãã圱é¿ãäžããŸãïŒãä»ã®ç æ ïŒç¥çµçŸæ£ãè³åäžãªã©ïŒã§ã¯ã30-2ãã¿ãŒã³ãã30°以äžã«ãŸã§åã¶ããå€§èŠæš¡ãªåçæ€æ»ã䜿çšãããããšããããŸãããããã£ãŠã24-2ã¯ç·å éã«ã¯åªããŠããŸãããèŠéã®é æ¹ã«è³ç å€ããããšãã£ãæžå¿µãããå Žåã«ã¯æé©ãªæ€æ»ã§ã¯ãããŸããã
匷åãããä»£æ¿æ€æ»
24-2ã®ç²ç¹ã«å¯ŸåŠãããããããæ°ããæ€æ»æŠç¥ãç»å ŽããŸãããæãäžè¬çãªãã®ã以äžã«ç€ºããŸãã
-
24-2CïŒCentralïŒïŒããã¯ãæ°ãããã³ããªãŒèŠéèšã§å©çšã§ããæ¹è¯ãããã°ãªããã§ããæšæºçãª24-2ã®ç¹ãç¶æãã€ã€ãäžå¿10°ã«è€æ°ã®äœçœ®ã远å ããŸãããã®æå³ã¯ã24-2ã®å©ç¹ãæãªãããšãªããåäžå¿æ§æ¬ æãæ€åºããããšã§ããå®éãæè¿ã®ã¬ãã¥ãŒã§ã¯ã24-2Cã*ãæšæºçãª24-2ãããè¿ éã§ãããå€ãã®[äžå¿]æ¬ æãç¹å®ããã*ããšã倿ããŠããããã®çµæã¯å®å šãª10-2æ€æ»ãšå¯æ¥ã«äžèŽããŠããŸã (pmc.ncbi.nlm.nih.gov)ãããç°¡åã«èšãã°ã24-2Cã¯24-2ãããå€ãäžå¿èŠéæ¬ æãçºèŠãã培åºãã10-2ãšã»ãŒåçã§ããã2ã€ã®åå¥ã®æ€æ»ãè¡ããããé«éã§ãã
-
10-2èŠéæ€æ»ïŒããã¯ãèŠèŠã®å åŽ10°ã2°ééã®68ç¹ã°ãªããã§æ€æ»ããå°çšã®äžå¿èŠéæ€æ»ã§ã (pmc.ncbi.nlm.nih.gov)ãç·å éãäžå¿èŠèŠã«åœ±é¿ãäžãããè ããããããå Žåã®æšæºçãªè£è¶³æ€æ»ãšãªã£ãŠããŸãããäžèšã®ããã«ã10-2ã¯24-2ãèŠéãæ¬ æããã°ãã°æ€åºããŸãã仿¥ã§ã¯ãäžéšã®å»åž«ã¯24-2ããå§ããäžå¿è¿ãã«äœãç°åžžãèŠãããå Žåããç·å 鿣è ã®èŠéã24-2ã§æãããªå€åããªãã«ããããããæªåããŠããå Žåã«10-2ã远å ããŸãããã¬ãŒããªããšããŠã10-2ã¯çŠç¹ãçµãããŠããïŒå¯ãªã°ãªããã®ããïŒããæéãããããŸãã24-2ã24°ã6°ééã®ç¹ãæ€æ»ããã®ãšã»ãŒåãæéã§ã10°ã2°ééã®ç¹ãæ€æ»ããããšãã§ããŸãã
-
30-2èŠéæ€æ»ïŒãã®å€ããã¿ãŒã³ã¯ãããåºã30°ã®èŠéïŒ76ç¹ïŒãæ€æ»ããŸã (www.ncbi.nlm.nih.gov)ãç¹æ®ãªçäŸãé€ããéåžžã¯æ¥åžžçãªç·å éã«ã¯å¿ èŠãããŸããããç¥çµçŒç§å»ãç¥çµç§å»ãåç²ãããåºç¯å²ã«åã¶ä»ã®ãã¿ãŒã³ãæ¢ãããã«30-2ã䜿çšããããšããããŸãã24-2ãæ¬è³ªçã«30-2ãããã®å€åŽã®ç¹ã®ãªã³ã°ãé€ãããã®ã§ããããšãèãããšã30-2ãžã®åãæ¿ãã¯ãããåšèŸºã®èŠéãéèŠã§ããå Žåã«ã®ã¿è¡ãããŸãã
-
é©å¿åããã³ã«ã¹ã¿ãã€ãºãããæ€æ»ïŒç ç©¶è ãäŒæ¥ã¯ãã¹ããŒããªèŠéæ€æ»æ¹æ³ãéçºããŠããŸããäŸãã°ãåºå®ãããã°ãªããã§ã¯ãªããæ°ããã¢ã«ãŽãªãºã ã¯ããªãã®ç®ã®ç¶æ ã«åºã¥ããŠæ€æ»ç¹ãéžæã§ããŸããçŸä»£ã®æŠç¥ïŒZESTãä»ã®ãã€ãžã¢ã³ã¢ã«ãŽãªãºã ãªã©ïŒã¯ãé¢å¿ã®ããé åã«çŠç¹ãåœãŠãããšã§æ€æ»æéãççž®ããããšãç®æããŠããŸãããŠã§ã¢ã©ãã«ãªããŒãã£ã«ãªã¢ãªãã£èŠéèšã¯ã24-2Cãã«ã¹ã¿ãã€ãºããããã¿ãŒã³ããã®å Žã§äœ¿çšã§ããŸãããããã®é©å¿åæ¹æ³ã¯ãŸã æ¥åžžçã«äœ¿çšãããŠããŸããããèŠéæ€æ»ã忣è ã®ç¹å®ã®æ¬ æãã¿ãŒã³ã«åãããŠèª¿æŽãããæªæ¥ãçŽæããŠããŸãã
èŠçŽãããšã24-2ã¯äž»åã§ããç¶ããŠããŸãããå»åž«ã¯å¿ èŠã«å¿ããŠè£å®çã«äœ¿çšããã±ãŒã¹ãå¢ããŠããŸããå€ãã®ã¯ãªããã¯ã§ã¯24-2ã宿œããäžå¿éšã®æå·ãçãããå Žåã«10-2ã远å ããŸãããŸããäž¡æ¹ãçµã¿åãããæ°ãã24-2Cãã¿ãŒã³ã䜿çšããã¯ãªããã¯ããããŸããéµã¯æè»æ§ã§ãã24-2ã®æ¢ç¥ã®ééãç¥ã£ãŠããããšã§ãäžå¿èŠèŠãè ããããŠããå Žåã«ãå»åž«ã¯è£è¶³çãªæ€æ»ãéžæã§ããŸãã
24-2æ€æ»äžã«äœãèµ·ããã
24-2èŠéæ€æ»ãäºå®ãããŠããæ£è ãããäžè¬çã«äœãæåŸ ã§ãããã«ã€ããŠèª¬æããŸãã
-
æºåïŒ æ€ åã«åº§ãããããæ¯ãã«çœ®ããçç®ãèŠããŸããæ©æ¢°ã¯ããªãã«åºå®ãããäžå¿ç¹ïŒæã«ã¯å°ããªå ãç»é¢äžã®é³¥ïŒãèŠãããã«æç€ºããŸããåšèŸºã«å ãèŠããŠããæ€æ»äžã¯åžžã«ãã®ç¹ãèŠã€ãç¶ããããšãéèŠã§ãã
-
æ€æ»ïŒ æ€æ»äžãæ§ã ãªæããã®å ãããªãã®èŠéã®ç°ãªãå Žæã§äžåºŠã«äžã€ãã€ç¹æ» ããŸããæå ã«ã¯ãã¿ã³ïŒã¯ãªãã«ãŒïŒããããŸããå ãç¹æ» ããã®ãèŠããã³ã«ããã¿ã³ãã¯ãªãã¯ããŸããç¹æ» ãèŠããªãå Žåã¯ããã®ãŸãŸåŸ ã¡ãŸããèŠéããç¹ã¯ãç¡åå¿ããšããŠèšé²ãããŸããæ©æ¢°ã¯54ã®ã°ãªããäœçœ®ã§ã©ã³ãã ã«å ãæç€ºããŸãããŸããåºèŠã確èªããããã«æç¹ã«å ãæç€ºããããšããããŸãïŒãããã¯èŠããã¯ãããããŸãããåå¿ããã£ãå Žåãç®ãåãããããšã«ãªããŸãïŒãæ€æ»ã¯å®å šã«èªåã§è¡ãããã¯ãªãã¯ãããšãã°ãã°ããŒãé³ãèãããŸãã
-
æèŠæéïŒ æšæºçãª24-2æ€æ»ã¯ãäžè¬çãªSITA Standardã¢ãŒãã§éåžžççŒã«ã€ãçŽ4ïœ5åããããŸã (glaucomatoday.com)ãïŒæ°ãããSITA FastãããFasterãæŠç¥ã¯ããããããã«ççž®ããæã«ã¯3åæªæºã«ããããšããããŸããããã®å粟床ããããã«äœäžããŸããïŒå»åž«ãŸãã¯æåž«ã¯ãè¿ãã®ã¢ãã¿ãŒã§ããªãã®æ€æ»ãç£èŠããŸããã³ã³ãã¥ãŒã¿ãŒãåºèп倱ãåœéœæ§å¿çãå€ãããïŒçŽ20ïœ30%以äžïŒãšç€ºããå Žåã¯ãäžæåæ¢ããŠæç€ºãå確èªããããããŸãã«æ€æ»ãåéãããããããšããããŸãã
-
å¿«é©æ§ïŒ æãèæ¯ã«åŸ®ããªå ããèŠããŸãããéšå±ãæãããããšã圹ç«ã¡ãŸãïŒæ©æ¢°ããã°ãã°ããããŸãïŒãçŒé¡ãã³ã³ã¿ã¯ãã¬ã³ãºãççšããŠããå Žåããã®ãŸãŸè£ çããŠããããšãã§ããŸãïŒãããã¯æåž«ãããªãã®åºŠæ°ã«åãããæ€æ»ã¬ã³ãºãæ©æ¢°ã«æ¿å ¥ãããããããŸããïŒããã£ãããšåºèŠããå ãç®ã§è¿œããªãããã«ããŠãã ããããªã©ãã¯ã¹ããŠãæ®éã«ãŸã°ãããããŠãã ãããèŠãããšæã£ãã®ã«èŠéããŠããŸã£ãŠãå¿é ãããŸãããæ©æ¢°ã«ã¯ãšã©ãŒãã§ãã¯æ©èœãçµã¿èŸŒãŸããŠãããéåžžãå¢çç·äžã®ç¹ã¯ç¹°ãè¿ãããŸãã
å šäœçã«ããã®äœéšã¯éåžžã«ãã£ãããšå¶åŸ¡ãããæ¹æ³ã§ãç®ã§ãã¢ã°ã©å©ãããããŠãããããªãã®ã§ããè¯ããã¥ãŒã¹ã¯ãç®ã«äœãè§Šããããšã¯ãªããå¯äžã®åªåã¯å°ããªç¹æ» ãèªèããããšã ãã ãšããããšã§ããã»ãšãã©ã®æ£è ã¯ãäžåºŠæ £ããŠããŸãã°ãããªãå®è¡å¯èœã ãšæããŸããå»åž«ã®èšé²ã®ããã«ãæ©æ¢°ã¯ã¬ããŒãã®äžéšã«ä¿¡é Œæ§æ°å€ãå°å·ããŸããçæ³çã«ã¯ãä¿¡é Œã§ããæ€æ»ã®ããã«ã¯ãåºèп倱ãåœéœæ§ãåœé°æ§ã®ãã¹ãŠãçŽ20ïœ30%æªæºã§ããã¹ãã§ã (glaucomatoday.com)ãå®éã«ã¯ãããªããæ³šææ·±ãååããã°ãéåžžãã®æ¡ä»¶ã¯æºããããŸãã
çµæã®æ¯èŒãšãã©ããŒã¢ããæ€æ»
ç·å éãããå Žåãå»åž«ã¯é²è¡ãç£èŠããããã«ã宿çã«ïŒäŸãã°6ïœ12ãæããšã«ïŒèŠéæ€æ»ãç¹°ãè¿ãããæ±ããã§ããããéèŠãªç¹ã¯ãæ¯ååãæ€æ»ãã¿ãŒã³ã䜿çšããããšã§ãããã©ããŒã¢ããã®èŠéæ€æ»ã¯ãä¿¡é Œæ§ã®ããæ¯èŒã®ããã«ã¯åãã°ãªããïŒåã24-2ã¬ã€ã¢ãŠãïŒã§è¡ãå¿ èŠããããŸããå®éãããå°éå®¶ã¯å»åž«ã«å¯Ÿãããå€åãé©åã«ç¹å®ããããã«ã¯ããã©ããŒã¢ããæ€æ»ã¯åãçš®é¡ã®æ€æ»ã§ããã¹ãã§ããããšå©èšããŠããŸã (glaucomatoday.com)ããã¿ãŒã³ãåãæ¿ããããšïŒäŸãã°ã24-2ã®ä»£ããã«10-2ãè¡ãããšïŒã¯é£ç¶æ§ãæã¡åããŸããã³ã³ãã¥ãŒã¿ãŒã®é²è¡åæã¯ãç°ãªã2ã€ã®ã°ãªãããçŽæ¥æ¯èŒããããšã¯ã§ããŸããããããã£ãŠããœãããŠã§ã¢ããŒã«ã§é²è¡ã远跡ããããã«ã¯ã24-2ã䜿ãç¶ããããšãéèŠã§ãïŒæ°ããäžå¿èŠéæ€æ»ãè£è¶³ãšããŠè¿œå ãããå Žåãé€ãïŒã
ããªã³ãã¢ãŠããåãåããšãå»åž«ã¯ããã€ãã®æ å ±ã«æ³šç®ããŸãã
-
æ°å€ããããšã°ã¬ãŒã¹ã±ãŒã«ãããïŒ åæ€æ»äœçœ®ã®ãã·ãã«ïŒdBïŒå€ã®è¡šã衚瀺ãããŸãïŒdBå€ãé«ãã»ã©ããã®ç¹ã§ã®æåºŠãè¯å¥œã§ãïŒããã®äžã«ã¯éåžžã°ã¬ãŒã¹ã±ãŒã«ãããããããæãé åã¯æåºŠãäœãããšãæå³ããŸãïŒæãã»ã©æãç¹æ» ãå°ãªãèŠããããšãæå³ããŸãïŒããã ãããããã®ã°ã¬ãŒã¹ã±ãŒã«ãããã¯èª€è§£ãæãå¯èœæ§ããããããå»åž«ã¯äžã®åå·®ãããããããéèŠããŸãã
-
å šåå·®ããã³ãã¿ãŒã³åå·®ããããïŒ ããªã³ãã¢ãŠãã¯ãã©ã®ç¹ãæ£åžžããéžè±ããŠãããã匷調衚瀺ããŸãããã¿ãŒã³åå·®ãããã¯ç¹ã«éèŠã§ããå šäœçãªäœäžïŒçœå éãªã©ã«ãããã®ïŒã調æŽãã屿çãªæ¬ æãç¹å®ããŸããp<5%ã2%ã1%ã§ç€ºãããç¹ã¯ããã°ãã°ããŒã¯ãããŸãïŒé»ãåè§ãäžè§åœ¢ïŒãå®éã«ã¯ãããªãã®èŠèŠãæ£åžžç¯å²å€ã«ããç®æã確èªã§ããŸãã
-
ææš â MDãPSDãVFIïŒ **å¹³ååå·®ïŒMDïŒããã¿ãŒã³æšæºåå·®ïŒPSDïŒ**ãªã©ã®æ°å€ãå°å·ãããŸããMDã¯æ£åžžããã®å¹³åå·®ã瀺ããŸããMDã0ã¯å¹Žéœ¢ã«å¯ŸããŠå®å šã«æ£åžžã§ããããšãæå³ããããè² ã®å€ã®MDïŒäŸãã°â5 dBïŒã¯ãããªãã®å šäœã®èŠéãæ£åžžæåºŠãã5 dBäœãããšãæå³ããŸã (glaucomatoday.com)ãïŒç°¡åã«èšãã°ã1 dBããšã«æãããçŽ10%å€åãããããMDãâ10ã¯ããªãã®æ¬ æã§ããïŒPSDïŒãŸãã¯ãã®çŸä»£çãªç䟡ç©ïŒã¯èŠéãããã«äžåäžã§ãããã瀺ããŸããPSDãé«ããšããããšã¯ã屿çãªæ¬ æãããããšãæå³ããŸãã**ç·å éåèŠéãã¹ãïŒGHTïŒ*ã衚瀺ãããããªãã®èŠéã®å šäœçãªåœ¢ç¶ãæ£åžžãã¿ãŒã³ãšæ¯èŒããŸããGHTããæ£åžžç¯å²å€ã*ãšè¡šç€ºãããå Žåãããã¯ããªãã®èŠéã®äžååãšäžååãååã«ç°ãªããããç·å éã§ããå¯èœæ§ãé«ãããšãæå³ããŸã (glaucomatoday.com)ã
-
ä¿¡é Œæ§ææšïŒ åºèп倱ãšèª€ã¯ãªãã¯ãäœãïŒ20ïœ30%æªæºïŒããšãåžžã«ç¢ºèªããŠãã ãããä¿¡é Œæ§ãäœãå Žåãå»åž«ã¯çµæãç¡èŠããåŸã§æ€æ»ãç¹°ãè¿ããããããŸããã
æ£è ãšããŠã¯ãããªã³ãã¢ãŠãã®çްãã詳现ãè§£éããã®ã¯æ··ä¹±ãããããããŸãããæãéèŠãªç¹ã¯ãMDã®æ°å€ãšãGHTãŸãã¯ãã¿ãŒã³åå·®ãæ£åžžç¯å²å€ã®äœããææããŠãããã©ããã§ããå®å®ããŠãããããã£ãããšå€åããMDã®åŸåïŒæ°ããé»ãæ¬ æã®åè§ããªãããšïŒã¯å®å¿ã§ããå åã§ããMDãèããäœäžããããç¹°ãè¿ãã®æ€æ»ã§æ°ããæ¬ æãçŸãããããå Žåã¯ãé²è¡ã瀺ããŸãããŸããããå»åž«ãç¹å®ã®ç¹ãããŒã¯ããå ŽåããããèŠéã®ã©ã®äœçœ®ã«å¯Ÿå¿ããã®ãå°ããŠã¿ãŠãã ãããããªãã¯ãããèªåã®èŠèŠã®äžéšïŒäŸïŒãå³äžèŠéã匱ããïŒãšé¢é£ä»ããããšããã§ãããããããŸããã
çµè«
24-2èŠéæ€æ»ã¯ãç·å éæ²»çã®æ ¹å¹¹ã§ãããã®å°äœã¯ãæ°å幎ã«ããã䜿çšãåºç¯ãªæ£åžžããŒã¿ããããŠå®çžŸã®ãããœãããŠã§ã¢ããŒã«ãããã¹ãŠ54ç¹ã°ãªãããäžå¿ã«æ§ç¯ãããŠããããšã«ãã£ãŠç¢ºç«ãããŸãã (www.ncbi.nlm.nih.gov) (www.ncbi.nlm.nih.gov)ããã®èšèšã¯ãç·å éãéåžžæåã«çºçããäž»èŠãªé åãå·§ã¿ã«ãµã³ããªã³ã°ããŠããŸããæ£è ã«ãšã£ãŠã¯ããã®æ€æ»ã¯è¿ éã§ãèŠéã远跡ããäžã§ä¿¡é Œæ§ãé«ãããšãæå³ããŸãã
ããããã©ã®æ€æ»ã«ãéçããããŸããçŸåšãå€ãã®å°éå®¶ã¯ã24-2ã®ç²ãééã§ã¯ãäžå¿ã«è¿ãåæã®æå·ãèŠéãå¯èœæ§ããããšåŒ·èª¿ããŠããŸãããã®ãããå»åž«ã¯é»æéšã«åé¡ããããšçãããå Žåãäžå¿èŠéæ€æ»ïŒ24-2CãŸãã¯10-2ïŒã远å ããããšããããŸã (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov)ãæ£è ãšããŠéèŠãªå®çšçãªãã€ã³ãã¯ãæ€æ»äžã«ãã£ãããšåºèŠããããšããã©ããŒã¢ããã§ã¯åããã¿ãŒã³ïŒ24-2ïŒã䜿çšããããäŸé ŒããããšããããŠäžå¿èŠèŠãäœäžããŠãããšæããå Žåã¯è¿œå æ€æ»ã«ã€ããŠé æ ®ãªãå°ããããšã§ãã
24-2æ€æ»ãäœã枬å®ããã©ã®ããã«è©äŸ¡ãããã©ãã§äžååã«ãªãå¯èœæ§ãããããçè§£ããããšã§ãããªãã¯ç·å éæ²»çã«ãããŠããæ å ±ã«åºã¥ããããŒãããŒãšãªãããšãã§ããŸããåžžã«å»åž«ãšçµæã確èªããæç¹ïŒç²ç¹ïŒã®æ©æçºèŠãç®æšã§ããããšãå¿ããªãã§ãã ãããããªãã®æ³šææ·±ããšå®æçãª24-2æ€æ»ã«ãããããªããšå»åž«ã¯ååããŠããªãã®èŠèŠãæå€§éã«ä¿è·ããããšãã§ããŸãã
